The comparative anxiolytic effects of placebo, imipramine and chlorimipramine using psychiatric and psychophysiological measurements.
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000704:Analysis of Variance; D001007:Anxiety / Q000188:drug therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D003984:Dibenzazepines / Q000627:therapeutic use*; D005260:Female; D005712:Galvanic Skin Response / Q000187:drug effects; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D008027:Light; D008297:Male; D008875:Middle Aged; D010919:Placebos / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D011674:Pulse / Q000187:drug effects; D013016:Sound; D013997:Time Factors
D001786:Blood Glucose; D003984:Dibenzazepines; D010919:Placebos; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D007099:Imipramine